Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › IL › Palos Heights › NPI 1831502269
Physician

Holcomb, Rachel

Holcomb, Rachel was paid $293K by Medicaid between Jan 2018 and Dec 2024, across 33 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 54% of everything it billed.

33Billing provider infoHOLCOMB, RACHEL
PALOS HEIGHTS, IL 60463
33aNPI1831502269assigned 06/03/2014
33bProvider typePediatrics Physician
28Total paid$293K
24GClaims14,233
24DCodes billed33
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Pediatrics Physician providers in Illinois

Rank by total paid#427 of 1,805
Median peer was paid$55K
This provider vs. median5.3×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$5.0K$10K$15K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2018438$15K
2019776$22K
20202,432$35K
20213,489$63K
20223,512$84K
20232,081$37K
2024incomplete1,505$35K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 54% 3,276 2,813 $157K
99214 Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 12% 479 375 $35K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 7.9% 448 327 $23K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe 5.1% 335 285 $15K
G2023 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 4.9% 595 500 $14K
99391 Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) 3.3% 140 119 $10K
99392 Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) 3.3% 125 94 $10K
99393 Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) 1.7% 66 60 $5K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets 1.3% 54 49 $4K
87428 1.3% 60 50 $4K
99394 Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) 1.1% 37 28 $3K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 103 83 $3K
21 more codes
87999 <1% 160 $3K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 182 $3K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) <1% 37 $1K
96127 <1% 63 $919.80
96110 Developmental screening, with scoring and documentation, per standardized instrument <1% 47 $755.67
83655 <1% 63 $747.18
36416 <1% 67 $373.10
90698 <1% 48 $307.20
94760 <1% 52 $228.80
90670 <1% 28 $179.20
87807 <1% 14 $140.84
85018 <1% 59 $134.56
90633 <1% 18 $115.20
99000 <1% 18 $31.30
3074F 0% 1,260 $0.00
3078F 0% 1,184 $0.00
1160F 0% 2,385 $0.00
1159F 0% 2,384 $0.00
99072 0% 259 $0.00
3210F 0% 84 $0.00
1003F 0% 103 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.